State-of-the-Art Lecture Session 58. Development of CCR5 Antagonists as a New Class of Anti-HIV Therapeutic <9:00- 9:30 am, Ballroom I-X>

Slide Session 59. HIV-1 Infection in Women/Pediatrics (abstracts 509-518) <10 am-12:30 pm, Ballrom I-III>

Slide Session 60. Antiretroviral Chemotherapy II (abstracts 519-528) <10 am-12:30 pm, Ballroom IV-VII>

Slide Session 61. Developments in Viral Entry and Tropism (abstracts 529-537) <10 am-12:15 pm, Ballroom VIII-X>

Symposium Session 62. Viral Reservoirs (abstracts S16 - S19) <2-4 pm, Ballroom I-V>

Symposium Session 63. Update on Epidemiology and Prevention (abstracts S20 - S23) <2-4 pm, Ballroom VIII-X>

Slide Session 64. Metabolic Complications of HIV-1 Disease (abstracts 538-541) <2-4 pm, Ballroom VI-VII>

Poster Session 65. PCP, Fungal, Mycobacterial and Other Opportunistic Infections (abstracts 542-552) <Wednesday, 4:30-6:30 PM>
Poster Session 66. CMV and Herpesvirus Infections (abstracts 553-557) <Wednesday, 4:30-6:30 PM>
Poster Session 67. HAV, HBV, and Other Hepatitis Viruses (abstracts 558-560) <Wednesday, 4:30-6:30 PM>
Poster Session 68. HCV Co-Infection (abstracts 561-576) <Wednesday, 4:30-6:30 PM>
Poster Session 69. Organ Transplantation in HIV-1-Infected Patients (abstracts 577-579) <Wednesday, 4:30-6:30 PM>
Poster Session 70. HHV-8 and Kaposi's Sarcoma (abstracts 580-589) <Wednesday, 4:30-6:30 PM>
Poster Session 71. Non-Hodgkin's Lymphoma and Other HIV-Related Malignancies (abstracts 590-594) <Wednesday, 4:30-6:30 PM>
Poster Session 72. JCV Infection and PML (abstracts 595-599) <Wednesday, 4:30-6:30 PM>
Poster Session 73. Clinical NeuroAIDS Issues (abstracts 600-602) <Wednesday, 4:30-6:30 PM>
Poster Session 74. Neuropathogenesis of HIV-1 (abstracts 603-612) <Wednesday, 4:30-6:30 PM>
Poster Session 75. CNS Reservoirs (abstracts 613-616) <Wednesday, 4:30-6:30 PM>
Poster Session 76. Hyperlactatemia, Hepatotoxicity, and Other Adverse Effects of Antiretroviral Therapies (abstracts 617-625B) <Wednesday, 4:30-6:30 PM>
Poster Session 77. Osteopenia and Bone Metabolism Disorders (abstracts 626-638) <Wednesday, 4:30-6:30 PM>
Poster Session 78. Wasting Syndromes (abstracts 640-643) <Wednesday, 4:30-6:30 PM>
Poster Session 79. Abnormalities of Fat Distribution and Insulin Resistance (abstracts 644-654B) <Wednesday, 4:30-6:30 PM>
Poster Session 80. Cardiovascular Disease Risk (abstracts 655-658) <Wednesday, 4:30-6:30 PM>
Poster Session 81. Mechanisms and Pathogenesis of Lipodystrophy Syndrome (abstracts 659-667) <Wednesday, 4:30-6:30 PM>
Poster Session 82. Antiretroviral Switch Studies for Metabolic Complications (abstracts 668-673) <Wednesday, 4:30-6:30 PM>
Poster Session 83. Epidemiologic Trends in Pediatrics HIV-1 Infection (abstracts 674-676) <Wednesday, 4:30-6:30 PM>
Poster Session 84. Antiretroviral Therapy in Treatment-Naïve and -Experienced Children (abstracts 677-685B) <Wednesday, 4:30-6:30 PM>
Poster Session 85. Immune Reconstitution in Children (abstracts 686-693) <Wednesday, 4:30-6:30 PM>
Poster Session 86. Perinatal Transmission: Trends in Use of Preventive Interventions (abstracts 694-704) <Wednesday, 4:30-6:30 PM>
Poster Session 87. Mechanisms and Factors Associated with Perinatal Transmission (abstracts 705-714) <Wednesday, 4:30-6:30 PM>
Poster Session 88. HIV-1 Genital Compartment Issues in Women (abstracts 715-721) <Wednesday, 4:30-6:30 PM>
Poster Session 89. HPV Infections in Women (abstracts 722-725) <Wednesday, 4:30-6:30 PM>
Poster Session 90. Pharmacokinetics of Antiretroviral Agents in Children (abstracts 726-729) <Wednesday, 4:30-6:30 PM>
Poster Session 91. Therapeutic Drug Monitoring (abstracts 730-736) <Wednesday, 4:30-6:30 PM>
Poster Session 92. Drug-Drug Interactions (abstracts 737-745) <Wednesday, 4:30-6:30 PM>
Poster Session 93. Pharmacokinetics of Antiretroviral Drugs (abstracts 746-753) <Wednesday, 4:30-6:30 PM>

Slide Session 94. Primary Infection (abstracts 754-761) <4:30-6:30 pm, Ballroom I-V>